Andrew Callos, EVP, Chief Commercial Officer: Cytokinetics CYTK Sell · Filed 25/03/13

Trade details

Type: Insider sale
Amount: $1,167,751.02
Shares · price: 26,771 sh · $43.62 a share
Held after: 37,663 sh
Stock: Cytokinetics CYTK
Person: Andrew CallosEVP, Chief Commercial Officer
Trade date: 25/03/13
Filed: 25/03/13
Days to filing: 0 days

Sold 41.5% of holdings

Share of holding sold: 41.5%

Cytokinetics trades, last 26 weeks

What else happened in Cytokinetics around then

Filed or reported within 30 days of the trade day · 25/02/11~25/04/12

Andrew Callos's recent trades

Andrew CallosEVP, Chief Commercial Officer
Planned sale10b5-1 planCytokinetics
Planned sale10b5-1 plan
Cytokinetics
CYTK
$1.9M
24,000 sh
$1.9M
Filed 07/30
Traded 07/30
Andrew CallosEVP, Chief Commercial Officer
Sell10b5-1 planCytokinetics
Sell10b5-1 plan
Cytokinetics
CYTK
$1.1M
15,000 sh
$1.1M
Filed 06/01
Traded 06/01
Andrew CallosEVP, Chief Commercial Officer
Sell10b5-1 planCytokinetics
Sell10b5-1 plan
Cytokinetics
CYTK
$875.5K
11,333 sh
$875.5K
Filed 05/05
Traded 05/05
Andrew CallosEVP, Chief Commercial Officer
Sell10b5-1 planCytokinetics
Sell10b5-1 plan
Cytokinetics
CYTK
$1M
15,857 sh
$1M
Filed 05/04
Traded 05/01
Andrew CallosEVP, Chief Commercial Officer
Sell10b5-1 planCytokinetics
Sell10b5-1 plan
Cytokinetics
CYTK
$948.9K
15,000 sh
$948.9K
Filed 04/30
Traded 04/30

Andrew Callos, Chief Officer — sold $1.2M of Cytokinetics CYTK · 41.5% of holdings · 10b5-1 plan | Whalegun